MabVax Therapeutics Holdings, Inc.
(Other OTC/NBB : MBVX)

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. -0.65%36.490.9%$1153.00m
JNJJohnson & Johnson -0.25%162.370.7%$1102.47m
LLYEli Lilly & Co. 1.34%201.141.1%$797.96m
ABBVAbbVie, Inc. 0.39%112.621.9%$726.43m
MRKMerck & Co., Inc. -0.89%82.450.7%$676.18m
BMYBristol-Myers Squibb Co. -0.72%66.261.0%$666.15m
AZNAstraZeneca Plc -0.63%52.241.2%$646.37m
ARCTArcturus Therapeutics Holdings, Inc. -1.68%67.300.0%$228.97m
VTRSViatris, Inc. 1.43%17.690.0%$194.67m
GRTSGritstone Oncology, Inc. 14.46%25.490.0%$175.56m
RPRXRoyalty Pharma Plc -2.89%50.350.2%$171.53m
NVSNovartis AG 0.25%96.930.2%$167.79m
GSKGlaxoSmithKline Plc -1.35%38.020.2%$146.69m
SNYSanofi -1.19%49.910.2%$118.17m
RGENRepligen Corp. -2.48%216.676.9%$80.89m

Company Profile

MabVax Therapeutics Holdings, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA.